Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Comparative efficacy of alemtuzumab and established treatment in the management of multiple sclerosis.
Participation as an Outcome in Multiple Sclerosis Falls-Prevention Research: Consensus Recommendation from the International MS Falls Prevention Research Network.
Primary spinal oligoastrocytoma mimicking longitudinally extensive transverse myelitis.
Distinct spatial distribution of microglia and macrophages following mesenchymal stem cell implantation in mouse brain.
Assessment of Optic Nerve Impairment in Patients with Neuromyelitis Optica by MR Diffusion Tensor Imaging.
Cross-validation of oxygen uptake prediction during walking in ambulatory persons with multiple sclerosis.
ALCAM and CD6 - multiple sclerosis risk factors.
Mediation of Protection and Recovery From Experimental Autoimmune Encephalomyelitis by Macrophages Expressing the Human Voltage-Gated Sodium Channel NaV1.5.
Genetic variation associated with the occurrence and progression of neurological disorders.
Dexterity, visual perception, and activities of daily living in persons with multiple sclerosis.
Disambiguating the optic nerve from the surrounding cerebrospinal fluid: Application to MS-related atrophy.
Adrenomedullin protects from experimental autoimmune encephalomyelitis at multiple levels.
Vitamin D3 alters microglia immune activation by an IL-10 dependent SOCS3 mechanism.
HINT1 peptide/Hsp70 complex induces NK cell-dependent immunoregulation in a model of autoimmune demyelination.
Overexpression of SIRT1 Protein in Neurons Protects against Experimental Autoimmune Encephalomyelitis through Activation of Multiple SIRT1 Targets.
HIV and lower risk of multiple sclerosis: beginning to unravel a mystery using a record-linked database study.
Pediatric Inflammatory Diseases. Part II: Acute Post-Infectious Immune Disorders.
Exogenous leukemia inhibitory factor stimulates oligodendrocyte progenitor cell proliferation and enhances hippocampal remyelination.
Molecular interplay between T-Antigen and splicing factor, arginine/serine-rich 1 (SRSF1) controls JC virus gene expression in glial cells.
Effectiveness of psychologically focused group interventions for Multiple Sclerosis: A review of the experimental literature.
Macrophages in inflammatory multiple sclerosis lesions have an intermediate activation status.
The effect of whole-body, repetitive, inhomogeneous static magnetic field-exposure on the symptoms of experimental autoimmune encephalomyelitis in mice.
Cortical N-acetyl aspartate is a predictor of long-term clinical disability in multiple sclerosis.
Concentration of 25(OH)D3 and calcium and phosphorus metabolism in patients suffering from relapsing-remitting multiple sclerosis. A pilot study.
Early diagnosis of Balo's concentric sclerosis by diffusion tensor tractography: a case report and literature review.
Pages
« first
‹ previous
…
491
492
493
494
495
496
497
498
499
…
next ›
last »